An 18-Month Prospective Evaluation of a Novel Hyaluronic Acid Filler (YYS 720) for 3-Dimensional Nasal and Chin Augmentation
Aesthetic Surgery Journal Open Forum · 14.01.2026 · 8
DOI: 10.1093/asjof/ojag146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Surgery Journal Open Forum, online erschienen am 14.07.2026. Verfasst von Minjeong Son. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LG Chem.
Abstract (Originalsprache)
Hyaluronic acid (HA) fillers typically require frequent reinjections. Next-generation fillers, like the Y-phasic YVOIRE® Y-solution (YYS) 720, require extended clinical validation to confirm their long-term performance and safety. This study evaluated 18-month clinical outcomes, safety, and satisfaction of YYS 720 for nasal and chin augmentation. In this prospective, single-arm study, 16 Korean patients received YYS 720 for the nose (n = 12) and chin (n = 7). Efficacy was evaluated through practitioner-assessed Global Aesthetic Improvement Scale (GAIS), patient-reported FACE-Q™ questionnaires, and objective 3-dimensional morphometric analysis. Safety was monitored through adverse event reporting and visual analog scale (VAS) pain scores. The GAIS responder rate was 100% through Month 12 and 84.21% at Month 18. FACE-Q scores significantly increased until Month 18 for the nose (80.67 ± 24.35, P = .0015) and Month 6 for the chin (86.00 ± 18.43, P = .0156). Three-dimensional analysis showed significant long-term improvements, with 1.73 ± 1.11 mL chin volume at Month 18 (P = .0061) and a 3.99 ± 2.81° nasofrontal angle increase at Month 12 (P = .0015) compared with baseline. The mean VAS score was low (1.69 ± 1.40). Only transient swelling and tenderness occurred in 4 patients, with no long-term delayed or serious adverse events. This pilot study provides preliminary evidence supporting the 18-month efficacy and safety of YYS 720. Given its pilot nature, these findings do not constitute claims of long-term reliability or durability, which were not formally assessed. Level of Evidence: 4 (Therapeutic)
Förderung
- LG Chem
Zitieren
APA
Son, M. (2026). An 18-Month Prospective Evaluation of a Novel Hyaluronic Acid Filler (YYS 720) for 3-Dimensional Nasal and Chin Augmentation. Aesthetic Surgery Journal Open Forum, 8. https://doi.org/10.1093/asjof/ojag146
Vancouver
Son M. An 18-Month Prospective Evaluation of a Novel Hyaluronic Acid Filler (YYS 720) for 3-Dimensional Nasal and Chin Augmentation. Aesthetic Surgery Journal Open Forum. 2026;8. doi:10.1093/asjof/ojag146
BibTeX
@article{Son2026,
author = {Son, Minjeong},
title = {An 18-Month Prospective Evaluation of a Novel Hyaluronic Acid Filler (YYS 720) for 3-Dimensional Nasal and Chin Augmentation},
journal = {Aesthetic Surgery Journal Open Forum},
year = {2026},
volume = {8},
doi = {10.1093/asjof/ojag146}
}
EUVIMED